The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABIVAX SA | SPONSORED ADS | 00370M103 | 5,411,348 | 378,416 | SH | SOLE | 378,416 | 0 | 0 | |||
| BEYOND AIR INC | COM | 08862L103 | 1,572,288 | 903,614 | SH | SOLE | 903,614 | 0 | 0 | |||
| BIOFRONTERA INC | COM NEW | 09077D209 | 776,562 | 504,261 | SH | SOLE | 504,261 | 0 | 0 | |||
| CARA THERAPEUTICS INC | COM | 140755109 | 1,409,493 | 1,548,893 | SH | SOLE | 1,548,893 | 0 | 0 | |||
| CELLECTAR BIOSCIENCES INC | COM NEW | 15117F807 | 2,473,482 | 621,478 | SH | SOLE | 621,478 | 0 | 0 | |||
| COMPASS PATHWAYS PLC | SPONSORED ADS | 20451W101 | 6,106,880 | 734,000 | SH | SOLE | 734,000 | 0 | 0 | |||
| CLEARSIDE BIOMEDICAL INC | COM | 185063104 | 3,966,667 | 2,592,593 | SH | SOLE | 2,592,593 | 0 | 0 | |||
| CYBIN INC | COM | 23256X100 | 5,772,460 | 13,960,000 | SH | SOLE | 13,960,000 | 0 | 0 | |||
| DELCATH SYSTEMS, INC. | COM NEW | 24661P807 | 4,955,209 | 1,038,828 | SH | SOLE | 1,038,828 | 0 | 0 | |||
| FORTRESS BIOTECH INC-NEW | COM NEW | 34960Q307 | 1,215,594 | 607,797 | SH | SOLE | 607,797 | 0 | 0 | |||
| GERON CORP | COM | 374163103 | 660,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | |||
| INSPIREMD INC | COM | 45779A846 | 1,626,035 | 686,062 | SH | SOLE | 686,062 | 0 | 0 | |||
| KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 3,415,502 | 287,985 | SH | SOLE | 287,985 | 0 | 0 | |||
| KIORA PHARMACEUTICALS INC | COM NEW | 49721T309 | 1,623,800 | 2,300,000 | SH | SOLE | 2,300,000 | 0 | 0 | |||
| LYRA THERAPEUTICS INC | COM | 55234L105 | 7,118,939 | 1,144,524 | SH | SOLE | 1,144,524 | 0 | 0 | |||
| MEDIWOUND LTD | SHS NEW | M68830112 | 6,925,357 | 485,990 | SH | SOLE | 485,990 | 0 | 0 | |||
| MYOMO INC | COM NEW | 62857J201 | 8,004,110 | 2,447,740 | SH | SOLE | 2,447,740 | 0 | 0 | |||
| OPTINOSE INC | COM | 68404V100 | 6,630,574 | 4,541,489 | SH | SOLE | 4,541,489 | 0 | 0 | |||
| OUTLOOK THERAPEUTICS INC | COM NEW | 69012T206 | 3,722,593 | 311,775 | SH | SOLE | 311,775 | 0 | 0 | |||
| POLYPID LTD | COM | M8001Q126 | 1,912,680 | 415,800 | SH | SOLE | 415,800 | 0 | 0 | |||
| PROFOUND MEDICAL CORP | COM NEW | 74319B502 | 4,549,330 | 533,333 | SH | SOLE | 533,333 | 0 | 0 | |||
| REZOLUTE INC | COM NEW | 76200L309 | 510,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | |||
| SPRUCE BIOSCIENCES INC | COM | 85209E109 | 1,185,466 | 1,508,419 | SH | SOLE | 1,508,419 | 0 | 0 | |||
| TALPHERA INC | COM NEW | 00444T209 | 781,735 | 758,966 | SH | SOLE | 758,966 | 0 | 0 | |||
| TONIX PHARMA HLDG CRP | COM NEW | 890260854 | 167,567 | 900,900 | SH | SOLE | 900,900 | 0 | 0 | |||
| TREVI THERAPEUTICS INC | COM | 89532M101 | 3,194,755 | 926,016 | SH | SOLE | 926,016 | 0 | 0 | |||
| UNICYCIVE THERAPEUTICS INC | COM | 90466Y103 | 2,593,911 | 1,879,646 | SH | SOLE | 1,879,646 | 0 | 0 | |||
| VERONA PHARMA PLC | SPONSORED ADS | 925050106 | 4,022,500 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | |||
| VERU INC | COM | 92536C103 | 3,150,450 | 4,500,000 | SH | SOLE | 4,500,000 | 0 | 0 | |||
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 5,253,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | |||
| XERIS BIOPHARMA HLDGS INC | COM | 98422E103 | 6,232,575 | 2,820,170 | SH | SOLE | 2,820,170 | 0 | 0 | |||
| AMYLYX PHARMACEUTICALS INC | CALL | 03237H901 | 0 | 50,000 | SH | Call | SOLE | 50,000 | 0 | 0 | ||
| INVESCO QQQ TR | UNIT SER 1 | 46090E953 | 7,000 | 100,000 | SH | Put | SOLE | 100,000 | 0 | 0 | ||
| SPDR SER TR | S&P BIOTECH | 78464A870 | 72,500 | 50,000 | SH | Put | SOLE | 50,000 | 0 | 0 | ||